发明名称 |
Modulators of miR-323-3p for the prevention or treatment of rheumatoid arthritis |
摘要 |
A miR-323-3p inhibitor is provided for the prevention or therapy of rheumatoid arthritis, comprising a sequence capable of forming a hybrid to miR-323-3p as an oligonucleotide or a vector from which such oligonucleotide is transcribed, or as a miRNA decoy or sponge. |
申请公布号 |
US9434944(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201214241456 |
申请日期 |
2012.08.31 |
申请人 |
UNIVERSITY OF ZURICH |
发明人 |
Gay Steffen;Connolly Mary;Ospelt Caroline |
分类号 |
C12N15/11;C12N15/113;C07H21/04 |
主分类号 |
C12N15/11 |
代理机构 |
JMB Davis Ben-David |
代理人 |
JMB Davis Ben-David |
主权项 |
1. A method for treating rheumatoid arthritis in a patient in need thereof, comprising administering to the patient a miR-323-3p inhibitor comprising a hybridizing sequence of nucleotides at least 90% identical to reverse complementary sequence of SEQ ID 1 or SEQ ID 2; thereby treating the rheumatoid arthritis. |
地址 |
Zurich CH |